Sunday, May 3, 2026

Ongoing Medicare Advantage network restructurings are fracturing provider panels, forcing plan members to either pay out-of-network costs or find new in-network clinicians. These disruptions are causing increased patient disenrollment from MA plans and directly impact practice panels and patient attribution. Billing managers must audit their active payer contracts for 2026 to confirm network status and model the patient-impact of any terminated agreements. Front-office teams should prepare for a surge in patient questions regarding network coverage and pre-authorizations.

Sweeping federal Medicaid cuts have placed at least five Wisconsin hospitals at immediate risk of closure. This follows broader warnings that a new $50 billion federal fund will not offset recent Medicaid reductions, threatening rural and community hospital viability nationwide. For practices that contract with or refer to these hospitals, these closures would disrupt referral networks and shift patient care burdens. Monitor the financial stability of key local hospital partners and prepare for potential shifts in patient volume and site-of-service billing.

The New York Post is reporting on an alleged fraud loophole within California's Medicaid program, Medi-Cal, tied to provider network arrangements. While specific enforcement actions are not yet detailed, the increased scrutiny signals broader payer and government focus on network integrity and billing compliance in Medicaid managed care. This follows a national pattern of heightened audit activity around Medicaid provider enrollment and claims submission.

A federal appeals court has ruled to block the mailing of mifepristone across the United States, reversing a 2023 FDA policy that allowed mail-order dispensing. This creates a nationwide barrier for medication abortion access, immediately affecting patients who rely on telehealth and mail-order services. The ruling directly challenges the Biden administration's efforts to protect abortion pill access through telehealth. Practices and pharmacies that have been prescribing or dispensing mifepristone via mail must halt this practice. Telehealth providers and prescribers will need to counsel patients on in-person dispensing requirements effective immediately.